Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 20, 2017 01:30 ET | Source: Oxurion NV

ThromboGenics Achieves Important Milestone in the Development of THR-149, A Novel Plasma Kallikrein Inhibitor for Diabetic Macular Edema

LEUVEN, Belgium, April 20, 2017 - ThromboGenics, a biotechnology company focusing on novel treatments for back of the eye disease and diabetic eye disease, announced it has achieved an important...
April 18, 2017 07:30 ET | Source: Envision Healthcare Corp.

Envision Healthcare Sets Earnings Release and Conference Call Dates for First-Quarter 2017 Results

NASHVILLE, Tenn. & GREENWOOD VILLAGE, Colo., April 18, 2017 (GLOBE NEWSWIRE) -- Envision Healthcare Corporation (NYSE: EVHC) today announced it will release its first-quarter 2017 financial...
April 16, 2017 23:00 ET | Source: Singapore Eye Bank

Singapore Eye Bank sets another record in local cornea donations in 2016

SINGAPORE--(Marketwired - Apr 16, 2017) - Singapore Eye Bank (SEB) breaks yet another record in its 26 years of history in cornea donations. It achieved the highest number of local cornea donations...
April 13, 2017 16:09 ET | Source: DIAGNOS Inc.

DIAGNOS Announces Private Placement

BROSSARD, QUEBEC--(Marketwired - April 13, 2017) - Diagnos Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in early detection of critical health issues through the use...
April 12, 2017 09:15 ET | Source: SECFilings.com

AXIM Biotech: New Clinical Program Featured in National Ophthalmology Publication Reignites Hope for Glaucoma Cannabis Therapy -- SECFilings.com

REDONDO BEACH, CA--(Marketwired - Apr 12, 2017) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the...
April 10, 2017 16:15 ET | Source: Ohr Pharmaceutical, Inc.

Ohr Pharmaceutical Provides Update on Ongoing Squalamine Clinical Trial in Wet-AMD

Results from Ongoing Clinical Trial in Wet-AMD (The MAKO Study) Expected by the End of Calendar 2017 or Early 2018Company Now Fully Funded Through Efficacy Data From Ongoing Trial and Into 2018 NEW...
April 10, 2017 16:01 ET | Source: Ohr Pharmaceutical, Inc.

Ohr Pharmaceutical Announces Closing of Public Offering of Common Stock and Warrants

NEW YORK, April 10, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that it has closed its previously announced...
April 10, 2017 09:45 ET | Source: Research and Markets

Global Tissue Engineering and Regeneration Technologies and Markets Research Report 2016-2021

Dublin, April 10, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Tissue Engineering and Regeneration: Technologies and Global Markets" report to...
April 10, 2017 09:45 ET | Source: Research and Markets

Global Markets for Emerging Medical Device Technologies, 2021 with Profiles of Major Players in the Field

Dublin, April 10, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Markets for Emerging Medical Device Technologies" report to their offering....
April 06, 2017 09:00 ET | Source: Lumenis Ltd.

Lumenis Exhibits Innovative Energy-based Technologies and the Launch of PiQo4 at 37th Annual Conference of the American Society for Laser Medicine and Surgery

SAN DIEGO, April 06, 2017 (GLOBE NEWSWIRE) -- Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic, and ophthalmic applications, proudly announces its newest...